Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ENDRA Life Sciences stock | $0.8768

Own ENDRA Life Sciences stock in just a few minutes.

Fact checked

ENDRA Life Sciences Inc is a diagnostics & research business based in the US. ENDRA Life Sciences shares (NDRA) are listed on the NASDAQ and all prices are listed in US Dollars. ENDRA Life Sciences employs 15 staff and has a market cap (total outstanding shares value) of USD$21.3 million.

How to buy shares in ENDRA Life Sciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for ENDRA Life Sciences. Find the stock by name or ticker symbol: NDRA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ENDRA Life Sciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$0.8768, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of ENDRA Life Sciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of ENDRA Life Sciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

ENDRA Life Sciences share price

Use our graph to track the performance of NDRA stocks over time.

ENDRA Life Sciences shares at a glance

Information last updated 2020-12-02.
Latest market closeUSD$0.8768
52-week rangeUSD$0.599 - USD$2.25
50-day moving average USD$0.7531
200-day moving average USD$0.8455
Wall St. target priceUSD$5.17
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.632

Buy ENDRA Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ENDRA Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ENDRA Life Sciences price performance over time

Historical closes compared with the close of $0.8768 from 2020-12-09

1 week (2021-01-08) -4.70%
1 month (2020-12-16) 15.98%
3 months (2020-10-15) 22.63%
6 months (2020-07-15) -1.92%
1 year (2020-01-15) -48.73%
2 years (2019-01-15) -53.61%
3 years (2018-01-12) 3.63
5 years (2016-01-12) N/A

ENDRA Life Sciences financials

Gross profit TTM USD$0
Return on assets TTM -172.37%
Return on equity TTM -602.99%
Profit margin 0%
Book value $0.133
Market capitalisation USD$21.3 million

TTM: trailing 12 months

Shorting ENDRA Life Sciences shares

There are currently 522,891 ENDRA Life Sciences shares held short by investors – that's known as ENDRA Life Sciences's "short interest". This figure is 12.7% down from 598,877 last month.

There are a few different ways that this level of interest in shorting ENDRA Life Sciences shares can be evaluated.

ENDRA Life Sciences's "short interest ratio" (SIR)

ENDRA Life Sciences's "short interest ratio" (SIR) is the quantity of ENDRA Life Sciences shares currently shorted divided by the average quantity of ENDRA Life Sciences shares traded daily (recently around 144047.10743802). ENDRA Life Sciences's SIR currently stands at 3.63. In other words for every 100,000 ENDRA Life Sciences shares traded daily on the market, roughly 3630 shares are currently held short.

However ENDRA Life Sciences's short interest can also be evaluated against the total number of ENDRA Life Sciences shares, or, against the total number of tradable ENDRA Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ENDRA Life Sciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ENDRA Life Sciences shares in existence, roughly 20 shares are currently held short) or 0.0229% of the tradable shares (for every 100,000 tradable ENDRA Life Sciences shares, roughly 23 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ENDRA Life Sciences.

Find out more about how you can short ENDRA Life Sciences stock.

ENDRA Life Sciences share dividends

We're not expecting ENDRA Life Sciences to pay a dividend over the next 12 months.

ENDRA Life Sciences share price volatility

Over the last 12 months, ENDRA Life Sciences's shares have ranged in value from as little as $0.599 up to $2.25. A popular way to gauge a stock's volatility is its "beta".

NDRA.US volatility(beta: 1.6)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ENDRA Life Sciences's is 1.6017. This would suggest that ENDRA Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ENDRA Life Sciences overview

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site